|
by Al-Essa, Reem K., Al-Rubaie, Mohammed, Walker, Stuart, Salek, Sam
Published 2015
Table of Contents:
“.... The Gulf States Assessment and Experience With the Centralised Procedure -- 9. The Pharmaceutical Companies...”Published 2015
Springer International Publishing
|
by Webb, Erin, Richardson, Erica, Vogler, Sabine, Panteli, Dimitra
Published 2022
“... price transparency would have a negative impact on accessibility, because pharmaceutical companies may...”Published 2022
Goverment of Malta, Office of the Deputy Prime Minister, Ministry for Health